ICU Sedation and Analgesia: Essential Medications
Pain Management Takes Priority Over Sedation
Pain assessment and treatment must be performed before administering sedatives in all critically ill adults. 1 The Society of Critical Care Medicine mandates an assessment-driven, protocol-based approach where treating pain is prioritized over providing sedatives. 1
First-Line Opioid Analgesics
The cornerstone opioids recommended for ICU pain management are:
- Fentanyl (0.35–0.5 μg/kg IV bolus, 0.7–10 μg/kg/hr infusion) - preferred for hemodynamically unstable patients due to minimal blood pressure effects 2
- Hydromorphone (0.2–0.6 mg IV bolus, 0.5–3 mg/hr infusion) - alternative for opioid-tolerant patients, though accumulation occurs with hepatic/renal impairment 2
- Morphine - effective and cost-effective for patients with stable cardiovascular function 3, 4
- Remifentanil (0.1-0.4 mcg/kg/min initial dose) - ultra-short-acting with organ-independent metabolism, recommended as first-line by the European Society of Cardiology for mechanically ventilated patients 5
Use opioids at the lowest effective dose for both continuous pain and procedural pain management. 1
Adjunctive Analgesics to Reduce Opioid Consumption
When seeking to minimize opioid doses and their adverse effects:
- Acetaminophen (IV) - conditionally recommended as adjunct to decrease pain intensity and opioid consumption 1, 2
- Low-dose ketamine (1–2 μg/kg/hr) - conditionally recommended as adjunct in post-surgical ICU patients to reduce opioid consumption 1, 2
- Nefopam - conditionally recommended either as adjunct or replacement for opioids where feasible 1
Neuropathic Pain Requires Specific Agents
For neuropathic pain, strongly recommend adding gabapentin, carbamazepine, or pregabalin to opioid therapy. 1 This is a strong recommendation with moderate-quality evidence. 1 These agents are also conditionally recommended for post-cardiovascular surgery pain. 1
Agents to Avoid for Routine Pain Management
- IV lidocaine - not recommended as routine adjunct to opioids 1, 2
- COX-1 selective NSAIDs - not recommended as routine adjunct, may worsen GI bleeding 1, 2
- Inhaled volatile anesthetics - strongly recommended against for procedural pain 1
Sedation Medications
First-Line Sedatives
Propofol is the preferred sedative for short-duration sedation and when intermittent awakening is required:
- Easily titrated with rapid offset when infusion stopped 3, 6
- Ideal for weaning from mechanical ventilation 3
- Critical dosing consideration: Reduce doses in elderly patients due to higher peak plasma concentrations causing hypotension, apnea, and oxygen desaturation 7
- Avoid rapid boluses in elderly, debilitated, or ASA-PS III/IV patients to minimize cardiorespiratory depression 7
- Contains 0.1 g fat per mL (1.1 kcal) - monitor triglycerides during extended use 7
Benzodiazepines (midazolam or lorazepam):
- Midazolam provides sleep and anxiolysis, frequently used via continuous infusion 3, 4
- Lorazepam offers cost-effective alternative by bolus or continuous infusion 4
- Diazepam shows shorter intubation time and cheaper cost than midazolam in low-resource settings 6
Alternative Sedatives for Specific Situations
Ketamine is preferred for:
- Asthmatic patients 6
- Hypotensive patients 6
- Patients requiring prolonged continuous sedation 6
- When benzodiazepines and narcotics fail to provide adequate sedation 4
Pentobarbital may be effective when combination of benzodiazepines and narcotics fails. 4
Critical Sedation Strategy: Light Sedation with Daily Interruption
Target light sedation with daily interruption, aiming for an awake and alert patient ready for weaning trials. 6 This approach improves outcomes compared to deep sedation.
Weaning Protocol
- Discontinue opioids and paralytic agents before weaning 7
- Adjust propofol to maintain light sedation throughout weaning process 7
- Continue light sedation until 10-15 minutes before extubation, then discontinue 7
- Pitfall: Abrupt discontinuation causes rapid awakening with anxiety, agitation, and resistance to mechanical ventilation 7
Pain Assessment Tools
Use validated tools routinely:
- 0-10 numeric rating scale for patients who can self-report 2
- Behavioral pain scales for patients unable to self-report 2
- RASS (Richmond Agitation-Sedation Scale) - preferred sedation assessment tool due to high validity, reliability, and ease of use for nurses 6
Drug Interactions and Special Populations
Concomitant Medications Requiring Dose Adjustments
- Valproate + propofol: Reduce propofol dose and monitor for increased sedation/cardiorespiratory depression 7
- Fentanyl + propofol in pediatrics: Risk of serious bradycardia - consider anticholinergic agents (atropine/glycopyrrolate) 7
- Premedication with narcotics or benzodiazepines reduces propofol induction requirements 7
Elderly Patients
- Require lower propofol doses for initiation and maintenance due to decreased volume of distribution and clearance 7
- Higher peak concentrations predispose to cardiorespiratory depression 7
- Mean propofol infusion rate approximately 20 mcg/kg/min (vs 38 mcg/kg/min in patients <55 years) 7
Renal and Hepatic Failure
- Propofol pharmacokinetics unchanged in chronic cirrhosis or chronic renal impairment 7
- Morphine-6-glucuronide (active metabolite) accumulates in renal failure - consider alfentanil as alternative 3
- Hydromorphone accumulates with hepatic/renal impairment 2
- Long-term propofol administration not evaluated in renal/hepatic failure 7
Common Pitfalls to Avoid
- Never use propofol for pediatric ICU sedation: FDA data shows increased mortality in pediatric ICU patients treated with propofol versus standard sedative agents 7
- Failure to reduce propofol infusion rate during extended use results in excessively high drug concentrations 7
- Pain on injection with propofol: Administer 1 mL of 1% lidocaine prior, or use antecubital veins instead of hand veins 7
- Do not exceed 20 mg lidocaine per 200 mg propofol when mixing, as higher ratios destabilize the emulsion 7
- Neuromuscular blocking agents: Only use after ensuring patients are asleep and pain-free; actions unpredictable in critically ill 3